Implications of p53 mutation spectrum for cancer etiology in gastric cancers of various histologic types from a high-risk area of central Italy.

Examination of p53 mutation spectra may provide clues to molecular mechanisms involved in different histologic types of gastric cancer. A total of 105 gastric cancer cases classified according to the Laurén's system were selected from a high-risk area around Florence, Italy. Exons 5-8 of the p53 gene were examined for mutations by the polymerase chain reaction-single strand conformation polymorphism technique and DNA sequencing, using DNA from formalin-fixed paraffin-embedded tissues. Mutation frequency was similar in intestinal-type (12/28) and unclassified tumors (9/18), but was significantly lower in diffuse cancers (12/57, P < 0.05). A similar frequency of p53 mutations was observed among tumor stages in both intestinal-type and unclassified cancers, but in diffuse tumors mutations tended to be associated with invasion beyond the muscularis propria. When base changes were considered, G:C-->A:T transitions at CpG sites were the most common mutations for all the three tumor types with 6 of 11 (55%) in intestinal type, 8 of 12 (67%) in diffuse type, and 5 of 8 (63 %) in unclassified tumors. Frequent p53 mutations in both intestinal-type and unclassified tumors support the hypothesis that unclassified tumors represent variants of the intestinal type and suggest that unclassified tumors, like the intestinal type, may also associate with environmental exposures. The predominance of G:C-->A:T transitions at CpG sites, which are associated with methyltransferase-induced DNA methylation at carbon 5 of cytosine, in all three tumor types suggests that the status of DNA methylation may be the major determinant for p53 mutations and may be also equally important in gastric carcinogenesis regardless of histology.

[1]  P. Correa,et al.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.

[2]  M. Manos,et al.  19 – SAMPLE PREPARATION FROM PARAFFIN-EMBEDDED TISSUES , 1990 .

[3]  S. Hirohashi,et al.  p53 Mutation in gastric cancer: A genetic model for carcinogenesis is common to gastric and colorectal cancer , 1993, International journal of cancer.

[4]  J. Hotchkiss,et al.  Potential genotoxicity of chronically elevated nitric oxide: a review. , 1995, Mutation research.

[5]  D. Amadori,et al.  p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  N. Muñoz,et al.  Time trends of intestinal and diffuse types of gastric cancer in Norway , 1971, International journal of cancer.

[7]  D. Rao,et al.  Chemistry and biology of DNA methyltransferases. , 1996, Critical reviews in biochemistry and molecular biology.

[8]  P. Laurén,et al.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.

[9]  R Holliday,et al.  DNA methylation and mutation. , 1993, Mutation research.

[10]  B. Singer In vivo formation and persistence of modified nucleosides resulting from alkylating agents. , 1985, Environmental health perspectives.

[11]  L. Loeb,et al.  8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G----T and A----C substitutions. , 1992, The Journal of biological chemistry.

[12]  G. Stemmermann,et al.  Pathology of gastric carcinoma in Japanese populations: comparisons between Miyagi prefecture, Japan, and Hawaii. , 1973, Journal of the National Cancer Institute.

[13]  C. Harris,et al.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[14]  J. Fraumeni,et al.  Diet, Helicobacter pylori, and p53 mutations in gastric cancer: a molecular epidemiology study in Italy. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  N. Muñoz,et al.  Histologic types of gastric carcinoma in high‐ and low‐risk areas , 1968, International journal of cancer.

[16]  D. Shibata,et al.  p53 mutations and microsatellite instability in sporadic gastric cancer: when guardians fail. , 1994, Cancer research.

[17]  Philip J. Farabaugh,et al.  Molecular basis of base substitution hotspots in Escherichia coli , 1978, Nature.

[18]  J. Fraumeni,et al.  Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy. , 1995, Cancer research.

[19]  M. Rugge,et al.  p53 alteration in gastric precancerous lesions. , 1994, The American journal of pathology.

[20]  J. Ferlay,et al.  Estimates of the worldwide incidence of eighteen major cancers in 1985 , 1993, International journal of cancer.

[21]  J. Parsonnet,et al.  Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. , 1991, Journal of the National Cancer Institute.

[22]  G. Coetzee,et al.  5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. , 1990, Science.

[23]  C. Poremba,et al.  Frequency and spectrum of p53 mutations in gastric cancer — a molecular genetic and immunohistochemical study , 2004, Virchows Archiv.

[24]  G. Friedman,et al.  Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.

[25]  T. Lindahl Repair of intrinsic DNA lesions. , 1990, Mutation research.

[26]  D. Amadori,et al.  A case‐control study of gastric cancer and diet in Italy , 1989, International journal of cancer.

[27]  K. Paigen,et al.  A simple, rapid, and sensitive DNA assay procedure. , 1980, Analytical biochemistry.

[28]  L. Loeb,et al.  Mutagenesis by metal-induced oxygen radicals. , 1994, Environmental health perspectives.

[29]  E. Bresnick,et al.  Inhibition of human O6-methylguanine-DNA methyltransferase by 5-methylcytosine. , 1994, Cancer research.

[30]  S. Mirvish Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. , 1995, Cancer letters.

[31]  D. Amadori,et al.  A case‐control study of gastric cancer and diet in Italy. III. Risk patterns by histologic type , 1991, International journal of cancer.